Correlation of Systemic Inflammation Parameters and Serum SLFN11 in Small Cell Lung Cancer-A Prospective Pilot Study.
Ivana SimićAzra GuzonjićJelena Kotur StevuljevićVesna Ćeriman KrstićNatalija SamardžićKatarina Savić VujovićDragana JovanovićPublished in: Biomedicines (2024)
The combination of inflammatory markers and the levels of two specific proteins (sPD-L1, SLFN11) could potentially serve as a non-invasive biomarker for predicting responses to DNA-damaging therapeutic agents in SCLC.